Wylei Appoints J&J Veteran Denice Torres to Board of Directors
Wylei Inc., an AI Predictive Content technology and marketing automation pioneer, today announced the appointment of Denice Torres to its Board of Directors. Torres is a recent past President for J&J, and an industry thought leader, with a strong background in digital marketing and executive management.
“The addition of Denice to the Wylei board is a major milestone for the company. Denice is a well-known and award-winning industry veteran and experienced executive. Her industry knowledge, mentoring and reach will be invaluable to Wylei,” said Wylei CEO Meg Columbia-Walsh.
The Wylei board provides leadership for carrying out Wylei’s mission to promote growth and revenue by leveraging advanced AI and machine learning technology to drive true 1:1 marketing personalization at scale. Torres joins the ranks of acclaimed board members including Meg Columbia-Walsh, John Martinson, Kevin Mably and Sheryl Goldstein.
Torres is a senior executive with an extensive healthcare and consumer experience developed across a 25-year career at Johnson & Johnson and Eli Lilly. At J&J, Torres served as Chief Strategy and Business Transformation Officer for the medical device sector, Co-Chair of the North America Consumer Business, President of McNeil Consumer Healthcare, and President of Janssen Pharmaceuticals, CNS. Prior to J&J, Torres held senior commercialization roles with Lilly.
She has extensive experience in corporate and portfolio strategy and has managed all major business functions. Torres has a strong background in marketing and is passionate about exceeding customer expectations. In 2015, Torres was selected Woman of the Year by Healthcare Business Women’s Association.
Denice Torres has a BS in Psychology from Ball State, JD from Indiana University, and MBA from the University of Michigan.